🇮🇳 Bioavailability & Bioequivalence (BA/BE) Studies Services for Ankleshwar

Empowering Ankleshwar’s Industry: US FDA | EU | WHO | PIC/S | CDSCO Compliance

PSUR Central, the specialized scientific arm of Zoesoe Exports Pvt Ltd, provides dedicated Periodic Safety Update Report (PSUR) and PBRER services for the industrial leaders of Ankleshwar.

As a key hub for Active Pharmaceutical Ingredients (APIs) and Bulk Drugs, Ankleshwar-based firms face unique safety reporting challenges when supplying to regulated markets. Since 2008, we have been the scientific partner of choice, ensuring that your safety documentation is as high-quality as your manufacturing standards.

Who We Support in Ankleshwar

We provide specialized pharmacovigilance expertise to the core of Gujarat's industrial belt:

  • API & Bulk Drug Manufacturers: Providing safety data support for Drug Master Files (DMFs) and global supply chains.

  • Generic Drug Exporters: Navigating the complex safety reporting requirements of the US, EU, UK, and ASEAN regions.

  • SMEs in GIDC Ankleshwar: Transitioning from domestic production to high-growth international exports.

  • Quality & Regulatory Teams: Addressing health authority observations, "Warning Letters," or deficiencies related to safety monitoring.

Our PSUR Services

We offer specialized support that bridges the gap between bulk manufacturing and global regulatory acceptance:

  • PSUR/PBRER Preparation: High-quality, technical report writing following ICH E2C (R2) standards for global submissions.

  • Safety Data Gap Analysis: Evaluating your current pharmacovigilance data against international expectations (US FDA, EMA).

  • Authority Query Handling: Expert assistance in responding to technical questions from health authorities regarding your product's safety profile.

  • Benefit-Risk Evaluation: Conducting robust scientific assessments to prove the continued safety and efficacy of your products.

  • API Safety Summaries: Specialized safety documentation for active ingredients being supplied to global pharmaceutical innovators.

Global Experience & Trusted Expertise

  • 750+ PSURs prepared and accepted by international regulators.

  • Since 2008: A long history of supporting Indian industry in reaching global markets.

  • Global Footprint: Extensive experience across Asia, Middle East, Africa, Europe, and North America.

  • Strong Regulatory Exposure: Proven success with US FDA, WHO, PIC/S, and CDSCO requirements.

Why Ankleshwar Companies Choose PSUR Central

"Turning manufacturing excellence into regulatory success."

  • API Focus: We understand the specific safety reporting nuances required for bulk drug manufacturers.

  • Non-Generic Approach: Our reports are scientifically written, providing in-depth signal detection rather than basic data entry.

  • Audit Readiness: We design reports to withstand rigorous inspections from the world's most demanding health authorities.

  • Confidentiality & Deadline Driven: We respect the fast-paced nature of the Ankleshwar industrial hub, delivering reports on time, every time.

Regulatory Standards Followed

Our documentation is meticulously prepared in alignment with:

  • ICH E2C (R2) Guidelines (The international standard for periodic safety reporting).

  • EU GVP Module VII (Periodic Safety Update Reports).

  • US FDA Post-Marketing Safety Reporting requirements (21 CFR 314.80).

  • CDSCO & PvPI requirements for the Indian market.

  • WHO and PIC/S aligned country regulations.

Get Started: Partner With Us

To initiate a customized project for your Ankleshwar-based facility, we typically require:

  1. Product/API List and target global markets.

  2. Approved Labeling/Specifications (SmPC / Product Monograph).

  3. Sales & Patient Exposure Data for the reporting period.

  4. Adverse Event Summaries (if applicable).

  5. Submission Timelines.

Contact PSUR Central today to ensure your global exports remain compliant and authority-ready.

Global PSUR Compliance. Science-Driven. Authority-Ready.